RXII - RXI Pharmaceuticals Corporation

Industry: Biotechnology Sector: Healthcare | Exchange: NASDAQ

Buy Candidate
Buy Score Rank #1881 out of #5176
Wed 26'th Jul 2017

PERIOD COVERED
2017-04-27 - 2017-07-26
CHANGE
3.06%
PRICE
$0.65
VOLUME
Sell
TREND

MV LONG
Buy

MV SHORT
Buy

PIVOT
Buy

MACD
Sell

BOLLINGER
Buy
Request Prediction
0.00%

RXI Pharmaceuticals Corporation Stock Analysis

Technical stock analysis for Wed 26'th Jul 2017

Buy candidate since 2017-07-25 Gain 3.13%

RXI Pharmaceuticals Corporation gained 3.06% in the last trading day, rising from $0.63 to $0.65 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has fallen in 6 of the last 10 days and is down by -5.84% for this period. Volume fell in the last day by -33 121 shares, and in total, 78 362 shares bought and sold for approximately $50 912. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Trend

RXI Pharmaceuticals Corporation lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 10.37% during the next 3 months and, with 90% probability hold a price between $0.62 and $0.84 at the end of this period.

Signals

RXI Pharmaceuticals Corporation holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $0.63 and $0.62. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday July 20, 2017, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Relative Strength Index (RSI)

RSI14 is 51 and the stock is currently not being overbought or oversold

Support & Resistance

RXI Pharmaceuticals Corporation finds support from accumulated volume at . On the upside the stock meets some resistance from accumulated volume at $0.75, $0.67 and $0.68.

Support: $0.64 Price: $0.6497 Resistance: $0.75
S: $0.64 Price: $0.6497 R: $0.75

Risk

This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.03 between high and low, or 4.76%. For the last week the stock has had a daily average volatility of 6.43%.

Our recommended stoploss: $0.62 (-4.26%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 4 days ago.)

Overall risk:

Very Low Low Medium High Very High

Overall risk:

           

Evaluation

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term. We have upgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Buy Candidate.

Buy Candidate

Buy RXII Shares
Your capital is at risk.

Learn To Identify Profitable Stock Chart Patterns.

FREE 7-Day Training

Learn To Identify Profitable Stock Chart Patterns.

FREE 7-Day Training
Help StockInvest improve by answering this short survey clicking HERE.

Build Your Watchlist

Add RXII My Watchlist

Recommended
books of the week

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Sign up to get FREE access to awesome features

Auto-portfolios that gain up to 30%

Request predictions from other users

Watchlist builder with notifications

News updates from 100+ financial publications

START FREE 5-DAY TRIAL
START FREE 5-DAY TRIAL